Mitsubishi UFJ Morgan Stanley Securities Co., Ltd.
Broker-DealerPosition in ABBV — AbbVie Inc.
CIK 1545545
TOKYO, M0
Position in ABBV
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$78,008
-$115,123 QoQ
Shares Held
310
-65.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
#4,040
of 4,153 holders
Holding Since
Mar 2022
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Mitsubishi UFJ Morgan Stanley Securities Co., Ltd. holds $563,108 across 8 Drug Manufacturers - General names. ABBV ranks #1 (13.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
310 | $78,008 | |
| 2 | LLY |
ELI LILLY & Co
|
65 | $77,962 | |
| 3 | MRK |
Merck & Co., Inc.
|
565 | $72,602 | |
| 4 | JNJ |
Johnson & Johnson
|
284 | $72,127 | |
| 5 | AMGN |
Amgen Inc
|
194 | $70,251 | |
| 6 | AZN |
Astrazeneca PLC
|
353 | $66,935 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
1,123 | $64,707 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
479 | $60,516 |
All Filings in ABBV
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $78,008 | 310 | Shares | Defined | 2026-07-15 | |
| 2026-03-31 | $193,131 | 888 | Shares | Defined | 2026-04-30 | |
| 2025-12-31 | $279,214 | 1,222 | Shares | Defined | 2026-02-10 | |
| 2022-12-31 | $4,848 | 30 | Shares | Defined | 2023-01-24 | |
| 2022-09-30 | $8,052 | 60 | Shares | Defined | 2022-11-08 | |
| 2022-06-30 | $9,189 | 60 | Shares | Defined | 2022-08-02 | |
| 2022-03-31 | $9,726 | 60 | Shares | Defined | 2022-05-04 | |
| No filing history on record for this holder in this stock. | ||||||